Patents by Inventor Linda C. Knight

Linda C. Knight has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5380646
    Abstract: Radiolabelled polypeptides derived from the Viperidae disintegrins are provided as well as a method for the detection of venous and arterial thrombi, pulmonary emboli and tumors or abscesses that have a thrombus component. Compositions suitable for parenteral administration comprising the radiolabelled polypeptides and a pharmaceutically acceptable carrier are also provided.
    Type: Grant
    Filed: October 19, 1992
    Date of Patent: January 10, 1995
    Assignee: Temple University of the Commonwealth System of Higher Education
    Inventors: Linda C. Knight, Alan H. Maurer
  • Patent number: 5288490
    Abstract: Thrombolytic hybrids are formed as covalent or non-covalent complexes of fibrin fragments and plasminogen activator molecules. Native plasmin degradation fragments of fibrin or non-native fibrin fragments are covalently or non-covalently linked to plasminogen activators such as t-PA, scu-PA, urokinase, streptokinase, and the like. Useful native fibrin fragments which may be utilized to form complexes with plasminogen activators include fragments E.sub.1, E.sub.2, E.sub.3, D and DD, and (DD)E complex. The fibrin fragment component targets the hybrid to vascular thrombi, immobilizing the plasminogen activator molecule onto the fibrin surface of the thrombus. Once localized on a thrombus surface, the plasminogen activator component of the hybrid activates only the clot-surface bound plasminogen transported by the fibrin fragment vehicle, without significant systemic activation of plasminogen.
    Type: Grant
    Filed: November 25, 1991
    Date of Patent: February 22, 1994
    Assignee: Temple University of the Commonwealth System of Higher Education
    Inventors: Andrei Z. Budzynski, Linda C. Knight, Ahmed A. Hasan
  • Patent number: 4867963
    Abstract: Nuclear magnetic resonance imaging of animal or human tissue is enhanced when a paramagnetic pyrophosphate compound is administered intraveneously as a contrast agent. The contrast agent is particularly useful in magnetic resonance imaging of area of tissue calcification, such as acute myocardial infarctions. Specific localization of paramagnetic pyrophosphate in ischemic and necrotic muscle cells at the periphery of a myocardial infarction makes accurate localization and sizing of the central infarct and peri-infarct zones possible.
    Type: Grant
    Filed: January 29, 1987
    Date of Patent: September 19, 1989
    Assignee: Temple University of the Commonwealth System of Higher Education
    Inventors: Alan H. Maurer, Linda C. Knight, Jeffrey A. Siegel
  • Patent number: 4427646
    Abstract: A method of locating thrombi in vivo comprising the steps of administering a radiolabeled peptide selected from the group consisting of Fragment E.sub.1 isolated from cross-linked fibrin, Fragment E.sub.2 isolated from crosslinked fibrin, and peptides having an amino acid sequence intermediate between Fragments E.sub.1 and E.sub.2 derived from crosslinked fibrin by plasmin digestion to a human or animal wherein the peptide is selectively incorporated or bound by forming a pre-formed thrombi and externally detecting the radiation emitted by the radiolabeled peptide. A composition containing the peptide used for locating thrombi is also disclosed.
    Type: Grant
    Filed: April 2, 1981
    Date of Patent: January 24, 1984
    Assignee: Research Corporation
    Inventors: Stephanie A. Olexa, Linda C. Knight, Andrei Z. Budzynski